Evidence map›Paper›PMID 28114888›Full record

ArticleBMC infectious diseases2017

Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model.

Jose Rojas-Caraballo, Julio López-Abán, Darwin Andrés Moreno-Pérez, Belén Vicente, Pedro Fernández-Soto, Esther Del Olmo, Manuel Alfonso Patarroyo, Antonio Muro

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Trickle infection withFrontiers in immunology · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Frontiers in immunology · 2019
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jose Rojas-CaraballoParasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain.
Julio López-AbánParasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain.
Darwin Andrés Moreno-PérezMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Belén VicenteParasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain.
Pedro Fernández-SotoParasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain.
Esther Del OlmoPharmaceutical Chemistry Department, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain.
Manuel Alfonso PatarroyoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Antonio MuroParasite and Molecular Immunology Laboratory, Tropical Disease Research Centre, (IBSAL-CIETUS), University of Salamanca, Salamanca, Spain. ama@usal.es.
Instituto de Investigación Biomédica de Salamanca · ESUniversidad del Rosario · COFundación Instituto de Inmunología de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFasciolosis remains a significant food-borne trematode disease causing high morbidity around the world and affecting grazing animals and humans. A deeper understanding concerning the molecular mechanisms by which Fasciola hepatica infection occurs, as well as the molecular basis involved in acquiring protection is extremely important when designing and selecting new vaccine candidates. The present study provides a first report of microarray-based technology for describing changes in the splenic gene expression profile for mice immunised with a highly effective, protection-inducing, multi-epitope, subunit-based, chemically-synthesised vaccine candidate against F. hepatica.

methodsThe mice were immunised with synthetic peptides containing B- and T-cell epitopes, which are derived from F. hepatica cathepsin B and amoebapore proteins, as novel vaccine candidates against F. hepatica formulated in an adjuvant adaptation vaccination system; they were experimentally challenged with F. hepatica metacercariae. Spleen RNA from mice immunised with the highest protection-inducing synthetic peptides was isolated, amplified and labelled using Affymetrix standardised protocols. Data was then background corrected, normalised and the expression signal was calculated. The Ingenuity Pathway Analysis tool was then used for analysing differentially expressed gene identifiers for annotating bio-functions and constructing and visualising molecular interaction networks.

resultsMice immunised with a combination of three peptides containing T-cell epitopes induced high protection against experimental challenge according to survival rates and hepatic damage scores. It also induced differential expression of 820 genes, 168 genes being up-regulated and 652 genes being down-regulated, p value <0.05, fold change ranging from -2.944 to 7.632. A functional study of these genes revealed changes in the pathways related to nitric oxide and reactive oxygen species production, Interleukin-12 signalling and production in macrophages and Interleukin-8 signalling with up-regulation of S100 calcium-binding protein A8, Matrix metallopeptidase 9 and CXC chemokine receptor 2 genes.

conclusionThe data obtained in the present study provided us with a more comprehensive overview concerning the possible molecular pathways implied in inducing protection against F. hepatica in a murine model, which could be useful for evaluating future vaccine candidates.

Indexed as

AnimalsAntibodies, HelminthCalgranulin AEpitopesFasciola hepaticaFascioliasisFemaleGene ExpressionGene Expression ProfilingInterleukin-12Interleukin-8Matrix Metalloproteinase 9MicePeptidesProtozoan VaccinesReceptors, Interleukin-8BAntibodies, HelminthCalgranulin ACXCL8 protein, humanEpitopesInterleukin-12Interleukin-8Matrix Metalloproteinase 9Mmp9 protein, mousePeptidesProtozoan VaccinesReceptors, Interleukin-8BRNA, MessengerS100a8 protein, mouseEpitopeFasciolosisGene expressionImmunologyMicroarraysVaccine

Identifiers

PMID28114888
PMCPMC5259852
OpenAlexW2582724478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.